Skip to main content

Asset management Ventures

By Skip Fleshman | 12:19 pm | January 22, 2021
Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.
By Jonah Comstock | 03:01 pm | May 21, 2019
The round, led by Foxkiser, brings the company's total funding to $10 million.